There are currently few data concerning the cerebrospinal fluid (CSF) penetration of daptomycin in patients with healthcare-associated meningitis. This study aims (1) to better characterize the pharmacokinetics of daptomycin in humans during a 7-day intravenous (IV) therapy course, and (2) to study the penetration of daptomycin in the CSF after IV infusion at the dose of 10 mg/kg.
Daptomycin Plasma and CSF Levels in Patients with Healthcare-Associated Meningitis
De Nicolò, Amedeo;D'Avolio, AntonioLast
2019-01-01
Abstract
There are currently few data concerning the cerebrospinal fluid (CSF) penetration of daptomycin in patients with healthcare-associated meningitis. This study aims (1) to better characterize the pharmacokinetics of daptomycin in humans during a 7-day intravenous (IV) therapy course, and (2) to study the penetration of daptomycin in the CSF after IV infusion at the dose of 10 mg/kg.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Piva2019_Article_DaptomycinPlasmaAndCSFLevelsIn.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
1.22 MB
Formato
Adobe PDF
|
1.22 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
